The Department of Laboratory Medicine at the Yale School of Medicine offers 2-3 years of structured post-doctoral research training in the broad field of Immunohematology to MDs, MD/PhDs, and PhDs interested in long term investigative careers in academia or elsewhere. This NIH-funded NRSA (T32) program is designed to provide the basic science, translational, and clinical research skills needed for individuals to become successful clinician-scientists and scientists.
The major areas of focus are:
- Stem Cells/Hematopoiesis
- Transfusion Medicine
- Host-Pathogen Interactions
- Vascular Biology/Transplantation
- Biomedical Engineering.
The core of the program is work in the research laboratory of one of over 30 Yale faculty members, drawn from 8 different Departments.
The program also offers the possibility of obtaining an additional advanced degree: a PhD in Investigative Medicine or a Masters in Health Sciences for trainees with an MD degree, or a Masters in Biomedical Engineering for any trainees. Individuals aiming for clinician-scientist careers, including MDs and MD/PhDs interested in any relevant clinical field, as well as PhD pathology and genetics clinician-scientists find the program especially well designed for their aspirations, as do academically oriented PhDs.
Applicants should have a graduate degree in Medicine or the Biological Sciences (MD, PhD, DVM, PharmD, DCLS). Most MD or MD/PhD applicants to the program will have been trained in Pathology and Laboratory Medicine and its subspecialties or in Medicine or Pediatric Hematology, although trainees throughout the years have also come from Cardiology, Anesthesiology, and many other disciplines. Most PhD applicants to the training will have done their graduate work in the biological sciences or in bioengineering, although trainees have also come through less traditional pathways such as Computer Sciences. Many of the clinician-scientist trainees will have come through one of the Yale Laboratory Medicine residencies
or fellowships (Transfusion Medicine
, Molecular Genetic Pathology
or Clinical Chemistry) on the physician-scientist track pathway; however, we very much welcome MDs and MD/PhDs who have already obtained their clinical training elsewhere and now wish to pursue a research career.
Trainees must meet the criteria for support on an NIH NRSA: a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence at the time of appointment.
Applications are accepted throughout the year. For applications and inquiries, please follow the instructions under “Apply”.